13F Filings History of Rosalind Advisors, Inc.
- Latest 13F filing
- Q1 2026 - 14 May 2026
- Latest reported 13F value
- $244,077,131
- Largest 13F holdings
-
DCTH XERS FENC SVRA PCVX EYPT XFOR VOR MDWD VSTM CLDX BCRX
+8 more
HELP CGON NSPR AVIR PROF VRDN PYPD MYO - Form 13F summary
-
- Rosalind Advisors, Inc. Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Rosalind Advisors, Inc. reported 32 equity holdings with a total reported market value of $244,077,131 for Q1 2026. Top reported holdings included DCTH, XERS, FENC, SVRA, and PCVX.
- Manager signature
- Steven Salamon - President, Rosalind Advisors, Inc.
- Manager location
- Toronto
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Rosalind Advisors, Inc. with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q1 2026
Latest value
$244,077,131
Quarter delta
-$16,785,493
Accepted
14 May 2026, 15:23
Rows shown
1-10 of 10
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 32 | $244,077,131 | +$81,928,962 | -$69,929,249 | +$11,999,713 | DCTH, XERS, FENC, SVRA, PCVX | 13F-HR | 14 May 2026, 15:23 |
| Q4 2025 | 29 | $260,862,624 | +$38,793,111 | -$78,888,796 | -$40,095,685 | DCTH, SVRA, FENC, XERS, VRDN | 13F-HR | 12 Feb 2026, 10:04 |
| Q3 2025 | 29 | $274,296,917 | +$60,281,422 | -$45,094,735 | +$15,186,687 | DCTH, CYTK, FENC, VSTM, RZLT | 13F-HR | 13 Nov 2025, 15:21 |
| Q2 2025 | 29 | $206,646,327 | +$36,472,993 | -$38,069,571 | -$1,596,578 | DCTH, FENC, CYTK, OCUL, IDYA | 13F-HR | 14 Aug 2025, 15:43 |
| Q1 2025 | 31 | $205,229,772 | +$56,438,597 | -$31,688,381 | +$24,750,216 | DCTH, VSTM, XERS, MYO, IDYA | 13F-HR | 14 May 2025, 13:18 |
| Q4 2024 | 28 | $185,657,489 | +$66,449,805 | -$51,098,995 | +$15,350,810 | DCTH, MYO, MDWD, CMRX, XERS | Restatement | 14 Feb 2025, 16:32 |
| Q3 2024 | 29 | $150,727,410 | +$22,859,588 | -$179,302,692 | -$156,443,104 | DCTH, MYO, CRMD, ABEO, MDWD | 13F-HR | 30 Oct 2024, 16:55 |
| Q2 2024 | 35 | $126,460,108 | +$42,239,784 | -$11,698,795 | +$30,540,989 | DCTH, MYO, MDWD, OPTN, ABEO | 13F-HR | 12 Jul 2024, 10:36 |
| Q1 2024 | 31 | $106,773,295 | +$31,347,856 | -$45,078,039 | -$13,730,183 | MYO, LYRA, MDWD, OPTN, XERS | 13F-HR | 25 Apr 2024, 17:21 |
| Q4 2023 | 27 | $119,521,116 | $0 | $0 | $0 | LYRA, MYO, ATXS, XERS, VRDN | 13F-HR | 14 Feb 2024, 11:48 |